Boyds is a global drug development consultancy helping to translate ideas into medicinal products and treatments for the benefit of patients.

Operating out of our offices in the US, UK and Europe, the team at Boyds provides a wide range of expertise and skills central to the development of pharmaceutical and biotechnology medicinal products and medical devices. We specialize in ATMPs, cell and gene therapies and orphan drugs, focusing on cutting-edge medicinal products and treatments.

Boyds works with pharma companies, biotechs, spin-outs and academic groups to support cutting-edge development. Our team has the expertise to help clients navigate the whole pathway from concept to bench to patient.